Beijing Succeeder Technology Inc. (SHA:688338)
32.11
+0.13 (0.41%)
Sep 29, 2026, 11:29 AM CST
SHA:688338 Revenue
Beijing Succeeder Technology had revenue of 72.67M CNY in the quarter ending June 30, 2026, with 3.34% growth. This brings the company's revenue in the last twelve months to 257.25M, down -9.99% year-over-year. In the year 2025, Beijing Succeeder Technology had annual revenue of 263.24M, down -13.94%.
Revenue (ttm)
257.25M
Revenue Growth
-9.99%
P/S Ratio
12.93
Revenue / Employee
959.88K
Employees
268
Market Cap
3.32B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 263.24M | -42.63M | -13.94% |
| Dec 31, 2024 | 305.87M | 30.38M | 11.03% |
| Dec 31, 2023 | 275.49M | 46.67M | 20.40% |
| Dec 31, 2022 | 228.81M | -11.10M | -4.63% |
| Dec 31, 2021 | 239.92M | 17.52M | 7.88% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Shanghai Kehua Bio-Engineering Co.,Ltd | 1.69B |
| Zhejiang Orient Gene Biotech | 1.01B |
| Ningbo David Medical Device | 584.68M |
| Chison Medical Technologies | 441.10M |
| Medprin Regenerative Medical Technologies | 400.85M |
| Tellgen | 392.11M |
| Shanghai General Healthy Information and Technology | 371.61M |
| CareRay Digital Medical Technology | 319.79M |